■评估局灶性肘部屈肌痉挛患者肌皮神经热射频的安全性和有效性。
■双向观察性随访研究。包括在2021年至2023年之间在肌皮神经中接受热射频治疗的继发于中枢神经系统损伤并伴有肘屈肌模式的局灶性痉挛患者。
■12名患者。
■在80°C下将超声引导的热射频应用于肌皮神经90s。在热射频之前和6个月时使用量表评估有效性以测量疼痛(VAS),痉挛(MAS),残疾(DAS),生活质量(SQol-6D),患者感知和医生感知满意度(PIG-C,PGA),和目标实现(GAS)。通过测角法评估肘关节的运动范围。通过评估副作用来评估安全性。
■患者在痉挛方面有统计学上的显着改善(p=0.003),严重的肘部屈曲(p=0.02),疼痛(p=0.046),功能正常(p<0.05),和痉挛相关的生活质量(三个部分p<0.05)。此外,达到治疗目标。实现了患者和医生感知的临床改善。关于副作用,两名患者有自我限制的感觉障碍,最长期限为1个月。
■肌皮神经中的热射频可以是安全的,有效的治疗与肘屈肌模式严重痉挛的患者。
UNASSIGNED: Evaluate safety and effectiveness of thermal radiofrequency in the musculocutaneous nerve in patients with focal elbow flexor spasticity.
UNASSIGNED: Ambispective observational follow-up study. Patients with focal spasticity secondary to central nervous system injury with elbow flexor pattern who received thermal radiofrequency treatment in the musculocutaneous nerve between 2021 and 2023 were included.
UNASSIGNED: 12 patients.
UNASSIGNED: Ultrasound-guided thermal radiofrequency was applied to the musculocutaneous nerve at 80°C for 90 s. Effectiveness was assessed prior to thermal radiofrequency and at 6 months using scales to measure pain (VAS), spasticity (MAS), disability (DAS), quality of life (SQol-6D), patient-perceived and physician-perceived satisfaction (PIG-C, PGA), and goal attainment (GAS). Elbow joint range of motion was evaluated via goniometry. Safety was evaluated by assessing side effects.
UNASSIGNED: Patients had statistically significant improvements in spasticity (p = 0.003), severe elbow flexion (p = 0.02), pain (p = 0.046), functioning (p < 0.05), and spasticity-related quality of life (p < 0.05 in three sections). Furthermore, treatment goals were attained. Patient- and physician-perceived clinical improvement was achieved. Regarding side effects, two patients had dysesthesia that was self-limiting, with maximum duration of 1 month.
UNASSIGNED: Thermal radiofrequency in the musculocutaneous nerve can be a safe, effective treatment for patients with severe spasticity with an elbow flexor pattern.